Metastatic Soft Tissue Sarcoma Active Not Recruiting Phase 2 Trials for Zalifrelimab (DB15632)

Also known as: Metastatic Soft-tissue Sarcoma / Metastatic Soft-Tissue Sarcomas

IndicationStatusPhase
DBCOND0055864 (Metastatic Soft Tissue Sarcoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04028063Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue SarcomasTreatment